Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
296.1000
6.75
(
2.33
%)
NSE
Mar 13, 2026
15:31 PM
New 52W Low in past week
Volume:
1.6M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
09 Aug 2022
296.10
2.33%
Suven Pharmaceuticals
Hold:
Cohance Lifesciences Ltd.
by
ICICI Direct
Target: 530
Target
ICICI Direct
Number of FII/FPI investors decreased from 206 to 171 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026, 05:55PM
India is (finally) opening up to the world
The Baseline |
13 Mar 2026, 05:37PM
Market closes lower amid high oil prices and an all time low for the Indian rupee against the …
Trendlyne Marketwatch |
13 Mar 2026, 04:04PM